Atria Investments’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-14,504
Closed -$468K 1208
2019
Q3
$468K Sell
14,504
-13
-0.1% -$444 0.02% 602
2019
Q2
$489K Buy
14,517
+580
+4% +$19.5K 0.02% 588
2019
Q1
$467K Buy
13,937
+1,128
+9% +$35.5K 0.02% 552
2018
Q4
$354K Sell
12,809
-2,117
-14% -$65.7K 0.02% 605
2018
Q3
$574K Buy
14,926
+7,971
+115% +$293K 0.02% 554
2018
Q2
$244K Buy
+6,955
New +$243K 0.01% 813

Other funds holding FFTY

Atria Investments's FFTY Position: Q4 2019 in Review

Atria Investments sold out of CapForce IBD 50 ETF (FFTY) in Q4 2019, closing a stake of 14,504 shares — an estimated $468K sold.

Atria Investments first reported a position in FFTY in Q2 2018 and held it in 6 quarters. The position peaked at $574K in Q3 2018. 81 funds tracked by Wall St. Rank hold FFTY as of Q4 2019.

  • Atria Investments reported no remaining CapForce IBD 50 ETF position as of Q4 2019 after selling out during the quarter.
  • Atria Investments sold 14,504 CapForce IBD 50 ETF shares in Q4 2019, an estimated $468K.
  • Atria Investments first reported a position in CapForce IBD 50 ETF in Q2 2018 and held it in 6 quarters.
  • Atria Investments's CapForce IBD 50 ETF position peaked at $574K in Q3 2018.
  • 81 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q4 2019.

Based on Atria Investments's 13F filing for Q4 2019, filed 11 Feb 2020.